In the latest session, NeuroOne Medical Technologies Corp (NASDAQ: NMTC) closed at $1.20 down -0.41% from its previous closing price of $1.21. In other words, the price has decreased by -$0.0050 from its previous closing price. On the day, 151171 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of NeuroOne Medical Technologies Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 3.68. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on March 29, 2022, Downgraded its rating to Hold and sets its target price to $2 from $6 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 27 ’23 when Christianson Mark sold 31,445 shares for $1.46 per share. The transaction valued at 45,859 led to the insider holds 300,594 shares of the business.
Christianson Mark sold 6,848 shares of NMTC for $9,269 on Dec 26 ’23. The Business Development Director now owns 332,039 shares after completing the transaction at $1.35 per share. On Dec 22 ’23, another insider, Christianson Mark, who serves as the Business Development Director of the company, sold 1,800 shares for $1.40 each. As a result, the insider received 2,520 and left with 338,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMTC now has a Market Capitalization of 31.38M and an Enterprise Value of 28.85M. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.03 while its Price-to-Book (P/B) ratio in mrq is 6.74. Its current Enterprise Value per Revenue stands at 10.25 whereas that against EBITDA is -2.16.
Stock Price History:
The Beta on a monthly basis for NMTC is 1.05, which has changed by -23.73% over the last 52 weeks, in comparison to a change of 29.57% over the same period for the S&P500. Over the past 52 weeks, NMTC has reached a high of $2.06, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 1.2186, while the 200-Day Moving Average is calculated to be 1.1970.
Shares Statistics:
For the past three months, NMTC has traded an average of 187.97K shares per day and 365.3k over the past ten days. A total of 23.93M shares are outstanding, with a floating share count of 22.03M. Insiders hold about 15.03% of the company’s shares, while institutions hold 25.05% stake in the company. Shares short for NMTC as of Mar 15, 2024 were 156.78k with a Short Ratio of 0.83, compared to 86.28k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.60% and a Short% of Float of 0.63%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.1, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.42 and -$0.42 for the fiscal current year, implying an average EPS of -$0.42. EPS for the following year is -$0.28, with 1 analysts recommending between -$0.28 and -$0.28.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for NMTC’s current fiscal year. The highest revenue estimate was $7M, while the lowest revenue estimate was $7M, resulting in an average revenue estimate of $7M. In the same quarter a year ago, actual revenue was $1.95M, up 258.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $13.3M in the next fiscal year. The high estimate is $13.3M and the low estimate is $13.3M. The average revenue growth estimate for next year is up 90.00% from the average revenue estimate for this year.
